{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:47:25Z","timestamp":1773812845696,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.atherosclerosis.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T12:01:47Z","timestamp":1478952107000},"page":"100-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7735-8313","authenticated-orcid":false,"given":"Beth A.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2013the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2015.49807","article-title":"Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel","volume":"11","author":"Banach","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib4","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.amjcard.2011.01.052","article-title":"Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations","volume":"107","author":"Pittman","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pds.3787","article-title":"Association between trajectories of statin adherence and subsequent cardiovascular events","volume":"24","author":"Franklin","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacl.2013.03.001","article-title":"Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education","volume":"7","author":"Wei","year":"2013","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2014.11.012","article-title":"Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study","volume":"238","author":"Morioka","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2014.10.118","article-title":"Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients","volume":"178","author":"Michalska-Kasiczak","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.clinthera.2014.02.023","article-title":"Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review","volume":"36","author":"Mergenhagen","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/1947-2714.153919","article-title":"Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation","volume":"7","author":"Khayznikov","year":"2015","journal-title":"N.\u00a0Am. J. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib11","first-page":"42","article-title":"Low plasma vitamin D levels and muscle-related adverse effects in statin users","volume":"16","author":"Eisen","year":"2014","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2265.2011.04321.x","article-title":"Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins","volume":"77","author":"Kurnik","year":"2012","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.12.016","article-title":"A\u00a0randomized trial of coenzyme Q10 in patients with confirmed statin myopathy","volume":"238","author":"Taylor","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib14","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2016.3608","article-title":"Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacl.2013.02.002","article-title":"A\u00a0randomized trial of coenzyme Q10 in patients with statin myopathy: rationale and study design","volume":"7","author":"Parker","year":"2013","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib16","first-page":"133","article-title":"Validation of the Brief pain inventory for chronic nonmalignant pain","volume":"5","author":"Tan","year":"2004","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0898-6568(94)00042-5","article-title":"Non-genomic signal transduction pathway of vitamin D in muscle","volume":"6","author":"De Boland","year":"1994","journal-title":"Cell Signal"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2011.05.021","article-title":"VDR activation of intracellular signaling pathways in skeletal muscle","volume":"347","author":"Boland","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib19","first-page":"435","article-title":"Reversible muscle weakness in patients with vitamin D deficiency","volume":"167","author":"Ziambaras","year":"1997","journal-title":"West J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12603-010-0287-3","article-title":"Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years","volume":"15","author":"Mastaglia","year":"2011","journal-title":"J.\u00a0Nutr. Health Aging"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib21","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1002\/jbmr.510","article-title":"Is vitamin D a determinant of muscle mass and strength?","volume":"26","author":"Marantes","year":"2011","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib22","first-page":"427","article-title":"Effects of pravastatin and cholestyramine on circulating levels of parathyroid hormone and vitamin D metabolites","volume":"12","author":"Ismail","year":"1990","journal-title":"Clin. Ther."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib23","doi-asserted-by":"crossref","first-page":"957174","DOI":"10.1155\/2010\/957174","article-title":"Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial","volume":"2010","author":"Rejnmark","year":"2010","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1755-5922.2010.00141.x","article-title":"STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D","volume":"29","author":"Ertugrul","year":"2011","journal-title":"Cardiovasc Ther."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10557-009-6181-8","article-title":"Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?","volume":"23","author":"Yavuz","year":"2009","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib26","first-page":"30001","article-title":"Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review","volume":"16","author":"Pereda","year":"2016","journal-title":"Reumatol. Clin."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bcpt.12482","article-title":"Low vitamin D levels and genetic polymorphism in the vitamin D receptor are associated with increased risk of statin-induced myopathy","volume":"118","author":"Ovesjo","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/1947-2714.179133","article-title":"Safety of 50,000-100,000 Units of vitamin D3\/week in vitamin D-deficient, hypercholesterolemic patients with reversible statin intolerance","volume":"8","author":"Jetty","year":"2016","journal-title":"N.\u00a0Am. J. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1185\/03007995.2012.702102","article-title":"Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D","volume":"28","author":"Riphagen","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib30","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s11606-008-0636-7","article-title":"Prevalence of musculoskeletal pain and statin use","volume":"23","author":"Buettner","year":"2008","journal-title":"J.\u00a0Gen. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1592\/phco.30.6.541","article-title":"Statin-associated muscle-related adverse effects: a case series of 354 patients","volume":"30","author":"Cham","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijcard.2016.02.028","article-title":"Increased creatine kinase with statin treatment may identify statin-associated muscle symptoms","volume":"209","author":"Taylor","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.11.011_bib33","first-page":"30321","article-title":"Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?","volume":"16","author":"Muntean","year":"2016","journal-title":"Drug Discov. Today"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:26:17Z","timestamp":1536247577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016314794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":33,"alternative-id":["S0021915016314794"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.011","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}